Erratum to

Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]

Uzoma Ibebuogu, Oluwaseyi Bolorunduro, Smith Giri, Samuel Dagogo-Jack, Blake G. Smith, Saibal Kar, Guy Reed

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalAmerican Journal of Cardiovascular Drugs
Volume15
Issue number4
DOIs
StatePublished - Aug 25 2015

Fingerprint

Platelet Glycoprotein GPIIb-IIIa Complex
Percutaneous Coronary Intervention
Heparin
Meta-Analysis
Diabetes Mellitus
Randomized Controlled Trials
Pharmaceutical Preparations
bivalirudin

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Cite this

@article{f29d3eb540224be4b39c587fcceb47c7,
title = "Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]",
author = "Uzoma Ibebuogu and Oluwaseyi Bolorunduro and Smith Giri and Samuel Dagogo-Jack and Smith, {Blake G.} and Saibal Kar and Guy Reed",
year = "2015",
month = "8",
day = "25",
doi = "10.1007/s40256-015-0118-3",
language = "English (US)",
volume = "15",
journal = "American Journal of Cardiovascular Drugs",
issn = "1175-3277",
publisher = "Adis International Ltd",
number = "4",

}

TY - JOUR

T1 - Erratum to

T2 - Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]

AU - Ibebuogu, Uzoma

AU - Bolorunduro, Oluwaseyi

AU - Giri, Smith

AU - Dagogo-Jack, Samuel

AU - Smith, Blake G.

AU - Kar, Saibal

AU - Reed, Guy

PY - 2015/8/25

Y1 - 2015/8/25

UR - http://www.scopus.com/inward/record.url?scp=84937967160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937967160&partnerID=8YFLogxK

U2 - 10.1007/s40256-015-0118-3

DO - 10.1007/s40256-015-0118-3

M3 - Comment/debate

VL - 15

JO - American Journal of Cardiovascular Drugs

JF - American Journal of Cardiovascular Drugs

SN - 1175-3277

IS - 4

ER -